SPLENDID: Bariatric surgery reduces the risk of developing cancer and death from cancer
Updated: Jun 8, 2022
Adults with obesity who achieved weight loss after bariatric surgery are associated with a 32% lower risk of developing cancer and a 48% lower risk of cancer-related death, compared with adults who did not have the surgery. The study, ‘Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity’, led by Cleveland Clinic researchers, was published by JAMA.
"Patients can lose 20 to 40% of their body weight after surgery and weight loss can be sustained over decades,” said Dr Ali Aminian, lead author of the study and director of Cleveland Clinic's Bariatric & Metabolic Institute. “The striking findings of this study indicate that the greater the weight loss, the lower the risk of cancer.”
Approximately 42% of American adults have obesity, according to the Centers for Disease Control and Prevention (CDC). Obesity increases the risk of developing 13 types of cancer that account for 40% of all cancers diagnosed every year in the United States, according to the CDC.
The SPLENDID (Surgical Procedures and Long-term Effectiveness in Neoplastic Disease Incidence and Death) research is a matched-cohort study that included more than 30,000 Cleveland Clinic patients. A group of 5,053 adult patients with obesity who had bariatric surgery (including Roux-en-Y gastric bypass (n=3,348; 66%) and sleeve gastrectomy (n=1,705; 34%) between 2004 and 2017 were matched 1:5 to a control group of 25,265 patients who did not have surgery for their obesity.
After ten years, 2.9% of patients in the bariatric surgery group and 4.9% of patients in the non-surgical group developed an obesity-associated cancer. The International Agency for Research on Cancer describes 13 types of cancer as obesity-associated cancers such as endometrial cancer, postmenopausal breast cancer, and cancers of the colon, liver, pancreas, ovary and thyroid.
After ten years, 0.8% of patients in the surgery group and 1.4% of patients in the non-surgical group died from cancer. Those findings indicate that bariatric surgery is associated with a 48% lower risk of dying from cancer.
The researchers noted that the benefits of bariatric surgery were seen in a wide range of study participants, including both women and men, young and old, and Black and white patients. In addition, benefits were similarly observed after both gastric bypass and gastric sleeve operations.
"According to the American Cancer Society, obesity is second only to tobacco as a preventable cause of cancer in the US," said the study's senior author, Dr Steven Nissen, Chief Academic Officer of the Heart, Vascular and Thoracic Institute. "This study provides the best possible evidence on the value of intentional weight loss to reduce cancer risk and mortality."
Numerous studies have shown the health benefits of bariatric or weight-loss surgery in patients with obesity. The Cleveland Clinic-led STAMPEDE study showed that following bariatric surgery, significant weight loss and control of type 2 diabetes last over time. The SPLENDOR study showed that in patients with fatty liver, bariatric surgery decreases the risk of the progression of liver disease and serious heart complications.
The SPLENDID study adds important findings to the literature focused on the link between obesity and cancer. Given the growing epidemic of obesity worldwide, these findings have considerable public health implications.
"Based on the magnitude of benefit shown in our study, weight loss surgery can be considered in addition to other interventions that can help prevent cancer and reduce mortality," added Dr Jame Abraham, chairman of the Hematology and Medical Oncology Department at Cleveland Clinic. "Further research needs to be done to understand the underlying mechanisms responsible for reduced cancer risk following bariatric surgery."
To access this paper, please click here